Li Bo, Cao Qian, Liu Zhuo
Department of Rehabilitation Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Department of Education, Jilin University Second Hospital, Changchun, China.
Front Med (Lausanne). 2022 Aug 3;9:981516. doi: 10.3389/fmed.2022.981516. eCollection 2022.
Colorectal cancer (CRC) is a worldwide disease threatening people's lives. Surgery and chemotherapy are still the main methods for CRC treatment. However, the side effects and chemotherapeutic drug resistance restrict the application of chemotherapy. Trametes Robiniophila Murr, also known as Huaier, is a traditional Chinese medicine that has been used for more than 1,600 years. Huaier extracts have promising anti-cancer effects on hepatoma, breast cancer, and gastric cancer. Nowadays, the tumor inhibition of Huaier on CRC has attracted more and more attention. This review mainly provides the possible anti-tumor mechanisms of Huaier for CRC treatment in apoptosis and inhibiting proliferation of tumor cells, preventing epithelial-mesenchymal transformation (EMT), weakening proliferation and differentiation of CRC stem cells, decreasing the vessel density in tumor tissues, and enhancing the immune system and chemotherapeutic efficacy. Huaier extract may be a good candidate for CRC treatment, especially when combined with other chemotherapeutic agents.
结直肠癌(CRC)是一种威胁全球人们生命的疾病。手术和化疗仍然是CRC治疗的主要方法。然而,副作用和化疗耐药性限制了化疗的应用。云芝,又称槐耳,是一种已使用1600多年的传统中药。槐耳提取物对肝癌、乳腺癌和胃癌具有良好的抗癌作用。如今,槐耳对CRC的肿瘤抑制作用越来越受到关注。本综述主要阐述了槐耳在CRC治疗中可能的抗肿瘤机制,包括诱导肿瘤细胞凋亡、抑制肿瘤细胞增殖、防止上皮-间质转化(EMT)、削弱CRC干细胞的增殖和分化、降低肿瘤组织中的血管密度,以及增强免疫系统和化疗疗效。槐耳提取物可能是CRC治疗的良好候选药物,尤其是与其他化疗药物联合使用时。